Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer
PaperCitations, authors & open-access status
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 32 citations, 2023 year and gold oa status.
32
Citations
2023
Year
gold
OA Status